Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPS: Pregabalin in Partial Seizures
NCT00141427Phase 4Completed
- Sponsor
- Viatris
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 4, open-label, single-arm trial of pregabalin in focal seizures, sponsored by Viatris. Primary endpoint: Mean percentage change in 28-day seizure frequency at 21 weeks. Started Nov 2004; status: completed.
02
Drugs
pregabalin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00141427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141427.